Clinical effect of Hepatic Artery Injection of Cinobufotalin Combined with Hyperthermic Perfusion Chemotherapy in the Treatment of Primary Hepatocellular Carcinoma
CAI Xiang-yang, ZHANG Dong
People in Nanjiang County, Sichuan Province 636000
Abstract：【Objective】To investigate the clinical effect of cinobufotalin injection through hepatic artery combined with hyperthermic perfusion chemotherapy in the treatment of primary hepatocellular carcinoma. 【Methods】Seventy-six patients with primary liver cancer were randomly divided into two groups, 38 cases each. The control group received transcatheter arterial chemoembolization (TACE) after transcatheter arterial infusion chemotherapy, while the observation group received hepatic artery injection of cinobufotalin combined with transcatheter arterial infusion chemotherapy (TACE) three times, one month apart. The efficacy, incidence of adverse reactions, PFS and OS of the two groups were compared.【Results】The disease control rate of the observation group was 63.16% (24/38), higher than that of the control group 41.67% (20/38), but there was no significant difference between the two groups (P>0.05). The incidence of pain in the observation group was 36.84% (14/38), significantly lower than that in the control group 63.16% (24/38), and there was a significant difference between the two groups (P<0.05). The PFS and OS of the observation group were (12.01±2.89) months and (19.32±5.48) months, which were significantly higher than those of the control group (10.03±3.00) months and (15.43 ±4.82) months, and there were significant differences between the two groups (all P<0.05). 【Conclusion】The anti-tumor effect of cinobufotalin intrahepatic artery injection combined with hyperthermic perfusion chemotherapy for primary hepatocellular carcinoma is better, the survival time of patients is prolonged and the pain is alleviated, which is worthy of clinical promotion.
蔡向阳, 张东. 肝动脉推注华蟾素联合热灌注化疗治疗原发性肝癌的疗效[J]. 医学临床研究, 2019, 36(7): 1282-1284.
CAI Xiang-yang, ZHANG Dong. Clinical effect of Hepatic Artery Injection of Cinobufotalin Combined with Hyperthermic Perfusion Chemotherapy in the Treatment of Primary Hepatocellular Carcinoma. JOURNAL OF CLINICAL RESEARCH, 2019, 36(7): 1282-1284.
2019, Vol. 36 
